HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Maharaj, R. Search for Related Content PubMed PubMed Citation Articles by Maharaj, R. Topic Collections EBM Notebook

Adding cost to number needed to treat: the COPE statistic

The University of the West Indies
St Augustine, Trinidad

Key Words: evidence-based medicine • statistics

The first 150 words of the full text of this article appear below.

During several years of teaching critical appraisal at both the undergraduate and postgraduate levels, I have used a modification of the number needed to treat (NNT). The COPE—the Cost of Preventing an Event—is a "back-of-the-envelope," user friendly, cost effectiveness analysis for clinicians and policy makers. Economic evaluations can be defined as the "comparative analysis of alternative courses of action in terms of both their costs and their consequences."¹ These analyses can be complex and sensitive to particular population groups and health systems and are often unavailable for clinicians (especially in developing nations). Traditionally, economists have used 1 of 5 methods for economic analysis: cost analysis, cost minimisation, cost effectiveness, cost utility, and cost benefit analyses.¹ The COPE is an approximate cost effectiveness statistic that can be calculated by clinicians for a new drug where a full economic evaluation is not available but where a randomised controlled trial (RCT) has been . . . [Full text of this article]